Structures for quality assurance and measurements for kidney replacement therapies: A multinational study from the ISN-GKHA.

Autor: Ekrikpo UE; Department of Internal Medicine, University of Uyo Teaching Hospital, Uyo, Nigeria., Davidson B; Division of Nephrology and Hypertension, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa., Calice-Silva V; Pro-Rim Foundation, Joinville, Santa Catarina, Brazil.; Department of Clinical Medicine, Faculty of Medicine, University of the Region of Joinville (UNIVILLE), Joinville, Santa Catarina, Brazil., Karam S; Division of Nephrology and Hypertension, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.; Division of Nephrology and Hypertension, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon., Osman MA; Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada., Arruebo S; The International Society of Nephrology, Brussels, Belgium., Caskey FJ; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Damster S; The International Society of Nephrology, Brussels, Belgium., Donner JA; The International Society of Nephrology, Brussels, Belgium., Jha V; George Institute for Global Health, New Delhi, India.; School of Public Health, Imperial College, London, UK.; Manipal Academy of Higher Education, Manipal, India., Levin A; Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Nangaku M; Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan., Saad S; Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada., Tonelli M; Department of Medicine, University of Calgary, Calgary, Alberta, Canada.; Canada and Pan-American Health Organization/World Health Organization Collaborating Centre in Prevention and Control of Chronic Kidney Disease, University of Calgary, Calgary, Alberta, Canada., Ye F; Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada., Okpechi IG; Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.; Division of Nephrology and Hypertension, University of Cape Town, Cape Town, South Africa.; Kidney and Hypertension Research Unit, University of Cape Town, Cape Town, South Africa., Bello AK; Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada., Johnson DW; Department of Kidney and Transplant Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia.; Centre for Kidney Disease Research, University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia.; Translational Research Institute, Brisbane, Queensland, Australia.; Australasian Kidney Trials Network, University of Queensland, Brisbane, Queensland, Australia.
Jazyk: angličtina
Zdroj: Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2024 Dec; Vol. 29 (12), pp. 873-883. Date of Electronic Publication: 2024 Oct 06.
DOI: 10.1111/nep.14402
Abstrakt: Aim: Optimal care for patients with kidney failure reduces the risks of adverse health outcomes, including cardiovascular events and death. We evaluated data from the third iteration of the International Society of Nephrology Global Kidney Health Atlas (ISN-GKHA) to assess the capacity for quality service delivery for kidney failure care across countries and regions.
Method: We explored the quality of kidney failure care delivery and the monitoring of quality indicators from data provided by an international survey of stakeholders from countries affiliated with the ISN from July to September 2022.
Results: One hundred and sixty seven countries participated in the survey, representing about 97.4% of the world's population. In countries where haemodialysis (HD) was available, 81% (n = 134) provided standard HD sessions (three times weekly for 3-4 h per session) to patients. Among countries with peritoneal dialysis (PD) services, 61% (n = 101) were able to provide standard PD care (3-4 exchanges per day). In high-income countries, 98% (n = 62) reported that >75% of centers regularly monitored dialysis water quality for bacteria compared to 28% (n = 5) of low-income countries (LICs). Capacity to monitor the administration of immunosuppression drugs was generally available in 21% (n = 4) of LICs, compared to 90% (n = 57) of high-income countries. There was significant variability between and within regions and country income groups in reporting the quality of services utilized for kidney replacement therapies.
Conclusion: Quality assurance standards on diagnostic and treatment tools were variable and particularly infrequent in LICs. Standardization of delivered care is essential for improving outcomes for people with kidney failure.
(© 2024 Asian Pacific Society of Nephrology.)
Databáze: MEDLINE
Externí odkaz: